Thyrocare Technologies Ltd

Thyrocare Tech. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Thyrocare Technologies Ltd

₹ 452 -2.15%
18 May - close price
thyrocare.com BSE: 539871 NSE: THYROCARE
About

Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India.

Key Points

Business Segments
1) Diagnostic Testing Services (92% in FY25 vs 94% in FY22): [1] [2] The company is one of the leading Pan-India diagnostic chains, offering a range of tests focused on early disease detection and health management. It provides 929 tests and 288 profiles, including 43 wellness packages under the “Aarogyam” brand. It processes 3 Bn investigations annually and can process 10 Bn annually. [3] [4]

Website BSE NSE
  • Market Cap ₹ 7,197 Cr.
  • Current Price ₹ 452
  • High / Low ₹ 538 / 291
  • Stock P/E 47.0
  • Book Value ₹ 35.2
  • Dividend Yield 1.55 %
  • ROCE 37.4 %
  • ROE 27.9 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • Stock is trading at 12.8 times its book value
  • Promoters have pledged 100% of their holding.
  • Promoter holding has decreased over last 3 years: -10.2%
  • Working capital days have increased from 35.6 days to 74.4 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Service Provider

Part of BSE Healthcare Nifty Microcap 250 Nifty Total Market BSE 1000 Nifty Smallcap 500

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
125 124 136 123 141 144 163 153 174 179 202 182 211
102 90 100 92 108 101 114 112 118 122 133 124 138
Operating Profit 23 33 37 31 34 42 49 40 56 57 69 58 73
OPM % 18% 27% 27% 25% 24% 29% 30% 26% 32% 32% 34% 32% 34%
2 0 2 2 3 3 2 4 5 4 2 -3 4
Interest 1 1 1 1 1 1 1 0 1 1 1 -0 1
Depreciation 9 9 9 11 10 9 10 15 12 9 10 20 13
Profit before tax 15 24 28 21 25 35 40 28 48 51 61 37 62
Tax % 33% 31% 28% 28% 23% 28% 27% 32% 54% 29% 29% 29% 30%
10 17 20 15 19 25 30 19 22 36 43 26 44
EPS in Rs 0.63 1.05 1.28 0.94 1.21 1.58 1.86 1.20 1.38 2.27 2.71 1.64 2.74
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
180 235 298 332 370 401 474 562 486 524 633 774
109 140 182 193 222 233 304 330 371 388 446 518
Operating Profit 71 95 115 139 148 168 171 232 115 136 188 256
OPM % 40% 40% 39% 42% 40% 42% 36% 41% 24% 26% 30% 33%
13 6 -16 21 14 -35 12 7 5 6 13 7
Interest 0 1 0 0 0 1 1 3 5 5 3 2
Depreciation 11 11 12 12 14 20 21 28 34 39 47 51
Profit before tax 73 89 87 148 147 112 161 207 81 98 151 210
Tax % 33% 34% 46% 35% 35% 29% 26% 27% 30% 28% 37% 29%
49 59 47 96 95 79 120 152 57 71 96 149
EPS in Rs 3.25 3.64 2.90 5.96 6.01 5.00 7.55 9.58 3.59 4.48 6.02 9.35
Dividend Payout % 157% 91% 115% 56% 111% 33% 110% 52% 167% 134% 116% 0%
Compounded Sales Growth
10 Years: 13%
5 Years: 10%
3 Years: 17%
TTM: 22%
Compounded Profit Growth
10 Years: 10%
5 Years: 6%
3 Years: 40%
TTM: 67%
Stock Price CAGR
10 Years: 8%
5 Years: 6%
3 Years: 43%
1 Year: 40%
Return on Equity
10 Years: 21%
5 Years: 20%
3 Years: 20%
Last Year: 28%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 51 54 54 54 53 53 53 53 53 53 53 159
Reserves 229 322 364 400 403 325 393 468 468 461 484 402
0 0 0 0 0 9 10 21 21 39 23 48
14 39 26 31 32 55 73 55 70 68 116 102
Total Liabilities 293 414 444 485 488 442 528 597 612 620 676 711
83 93 89 103 108 112 119 149 157 159 158 180
CWIP 6 1 2 0 1 4 8 2 1 1 14 3
Investments 162 266 299 315 289 239 274 259 274 291 284 274
42 55 54 68 89 88 127 186 180 169 221 254
Total Assets 293 414 444 485 488 442 528 597 612 620 676 711

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
36 67 89 112 97 136 111 106 120 155 191 206
-21 -19 -40 -48 -3 27 -53 -12 -32 -80 -55 -21
-23 -45 -48 -65 -96 -163 -58 -87 -88 -84 -124 -167
Net Cash Flow -7 3 1 -1 -3 1 0 6 1 -9 12 18
Free Cash Flow 32 52 79 86 78 127 77 66 99 114 144 191
CFO/OP 83% 103% 112% 115% 107% 108% 91% 70% 129% 135% 121% 104%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 9 11 7 10 11 14 34 60 63 28 40 33
Inventory Days 47 54 64 66 54 60 50 54 63 106 93 81
Days Payable 5 8 4 23 19 62 48 30 52 83 141 96
Cash Conversion Cycle 51 57 68 53 46 12 37 84 74 51 -9 18
Working Capital Days 52 15 28 11 4 -12 7 45 34 14 18 74
ROCE % 27% 27% 29% 33% 31% 36% 37% 41% 15% 18% 26% 37%

Insights

In beta
Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Number of Tests Conducted
Million

Log in to view insights

Please log in to see hidden values.

Login
Number of Samples Processed (Pathology)
Million
Number of Active Franchisees
Count
Number of Labs (Pathology)
Count
Number of PET-CT Scans (Radiology)
Count
Average Lab Turnaround Time (Post-receipt)
Hours

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

17 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
71.14% 71.14% 71.11% 71.11% 71.11% 71.11% 71.06% 71.06% 71.06% 71.06% 60.93% 60.92%
3.44% 3.46% 3.35% 2.90% 2.49% 1.93% 2.77% 2.41% 3.23% 4.85% 4.96% 5.37%
13.46% 13.33% 13.89% 14.88% 14.89% 14.79% 14.68% 14.97% 14.54% 13.47% 20.52% 21.00%
11.95% 12.08% 11.64% 11.11% 11.49% 12.15% 11.49% 11.57% 11.18% 10.61% 13.61% 12.71%
No. of Shareholders 76,29272,00068,84464,82361,63659,37756,66657,40354,56654,14277,61973,377

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls